The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Clarithromycin 500 mg Powder for Concentrate for Solution for Infusion

500 milligram(s) Powder for concentrate for solution for infusion

Amdipharm LimitedPA1142/022/001

Main Information

Trade NameClarithromycin 500 mg Powder for Concentrate for Solution for Infusion
Active SubstancesClarithromycin
Strength500 milligram(s)
Dosage FormPowder for concentrate for solution for infusion
Licence HolderAmdipharm Limited
Licence NumberPA1142/022/001

Group Information

ATC CodeJ01FA Macrolides
J01FA09 clarithromycin

Status

Authorised/WithdrawnAuthorised
Licence Issued13/08/2010
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back